Thorax Trauma Severity Score in Chest Trauma: A Study in Iraq
Launched by AL-NAHRAIN UNIVERSITY · Dec 16, 2024
Trial Information
Current as of May 24, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a tool called the Thorax Trauma Severity Score (TTSS), which helps doctors predict how severe chest injuries are and whether patients might need intensive care or other advanced treatments. The researchers want to find out how accurately this scoring system can assess the risk of serious outcomes, like death or the need for surgery, specifically in patients who arrive at a hospital in Iraq after a chest injury. They will also look at factors like age, gender, and other health conditions that might affect the score's accuracy.
To participate in this study, patients must arrive at the emergency department within 4 hours of their injury and have a chest trauma that can be assessed. Both patients and their guardians will need to provide consent to join. During the study, participants will be evaluated using the TTSS when they first arrive at the hospital, and their medical information will be collected to help understand how well the score predicts outcomes. This trial is important because it aims to improve care for patients with chest injuries in settings where resources may be limited.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patients who present within 4 hours of sustaining the injury.
- • Patients presenting to the emergency department with thoracic trauma.
- • Patients or their legal guardians must provide informed consent to participate in the study.
- Exclusion Criteria:
- • Patients with incomplete clinical data or those discharged before scoring can be performed.
- • Pregnant patients (due to specific physiological considerations not accounted for by the scoring system).
- • Patients who succumb to their injuries before scoring or baseline data collection.
- • Pediatric patients under 18 years of age.
About Al Nahrain University
Al-Nahrain University is a leading academic institution dedicated to advancing medical research and education in Iraq. With a focus on innovative clinical trials, the university aims to enhance healthcare outcomes through rigorous scientific investigation and collaboration with local and international partners. Its commitment to ethical research practices and adherence to regulatory standards positions Al-Nahrain University as a pivotal contributor to the development of new therapeutic interventions and the overall improvement of public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baghdad, , Iraq
Patients applied
Trial Officials
Luma K Mohammed, Assistant professor
Study Director
Al-Nahrain University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported